Clinical Trials · NCT01128894
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- GlaxoSmithKline
- Enrollment
- 841
- Start date
- May 2010
- Locations
- 173 sites, 8 countries
- Primary endpoint
- Mean Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 32